ࡱ> CEBx UBbjbjVV 4r<<4: vv8<A*n(zz,  *"*"*"*"*"*"*$,.F*X"zF*U[*j * *rx'Tx(c#R' *q*0*'i/ufi/x(i/x(8LZ fS888F*F*888*i/888888888v : Second Examination Finance 3320 - Spring 2011 (Moore) R-Number: ____________________ Printed Name: ____________________ Section and Time: ____________________ Ethical conduct is an important component of any profession. The Texas Tech University Code of Student Conduct is in force during this exam. Students providing or accepting unauthorized assistance will be assigned a score of zero (0) for this piece of assessment. Using unauthorized materials during the exam will result in the same penalty. Ours should be a self-monitoring profession. It is the obligation of all students to report violations of the honor code in this course. By signing below, you are acknowledging that you have read the above statement and agree to abide by the stipulated terms. Students Signature: ______________________________ Clearly Fill in the appropriate bubble on the Scantron form for each of the following questions. Choose the BEST response. There is only one answer per question. 1. Which of the following statements is CORRECT? a. A reduction in inventories would have no effect on the current ratio. b. An increase in inventories would have no effect on the current ratio. c. If a firm increases its sales while holding its inventories constant, then, other things held constant, its inventory turnover ratio will increase. d. A reduction in the inventory turnover ratio will generally lead to an increase in the ROE. e. If a firm increases its sales while holding its inventories constant, then, other things held constant, its fixed assets turnover ratio will decline. 2. Which of the following statements is CORRECT? a. If a security analyst saw that a firms days sales outstanding (DSO) was higher than the industry average, and was increasing and trending still higher, this would be interpreted as a sign of strength. b. If a firm increases its sales while holding its accounts receivable constant, then, other things held constant, its days sales outstanding will decline. c. There is no relationship between the days sales outstanding (DSO) and the average collection period (ACP). These ratios measure entirely different things. d. A reduction in accounts receivable would have no effect on the current ratio, but it would lead to an increase in the quick ratio. e. A high average DSO indicates that none of its customers are paying on time. In addition, it makes no sense to evaluate the firm's DSO with the firm's credit terms. 3. Companies E and P each reported the same earnings per share (EPS), but Company Es stock trades at a higher price. Which of the following statements is CORRECT? a. Company E probably has fewer growth opportunities. b. Company E is probably judged by investors to be riskier. c. Company E must have a higher market-to-book ratio. d. Company E trades at a higher P/E ratio. e. Company E must pay a lower dividend. 4. Which of the following statements is CORRECT? a. Debt management ratios show the extent to which a firm's managers are attempting to magnify returns on owners' capital through the use of financial leverage. b. Other things held constant, the more debt a firm uses, the higher its profit margin will be. c. Other things held constant, the higher a firm's debt ratio, the higher its TIE ratio will be. d. Debt management ratios show the extent to which a firm's managers are attempting to reduce risk through the use of financial leverage. The higher the debt ratio, the lower the risk. e. Other things held constant, the more debt a firm uses, the higher its operating margin will be. 5. Austin Financial recently announced that its net income increased sharply from the previous year, yet its net cash provided from operations declined. Which of the following could explain this performance? a. The companys dividend payment to common stockholders declined. b. The companys expenditures on fixed assets declined. c. The companys cost of goods sold increased. d. The companys depreciation expense declined. e. The companys interest expense increased. Use the Financial Statements for Cantel Medical Corporation for the next four questions. 6. Compute Days Supply of Inventory for the year ended 7/31/2008 and assume a 365 day year. 5.92 turns 7.84 turns 46.55 Days 61.65 Days 71.76 Days Compute Return on Equity for the year ended 7/31/2008. 5.01% 5.15% 5.61% 9.85% 10.93% If the company wanted to change its Total Liabilities to Equity ratio on the very last day of the 2008 financial year from its existing level to 1.20, how much would it have to borrow on 7/31/2008 to accomplish this? $75,606 $77,483 $91,976 $186,084 $202,454 If Cantel had reduced its average collection period on accounts receivables (DSOs) by 3 days during 2009, how much is the maximum additional cash that could be on the balance sheet at year end? Assume 365 day year. $8.36 $43.66 $46.66 $2,049.65 $29,831.35 10. An investment will pay a lump sum of $1,000 exactly 3 years from today. The nominal interest rate is 6%, semiannual compounding. Which of the following statements is CORRECT? a. The periodic interest rate is greater than 3%. b. The periodic rate is less than 3%. c. The present value would be greater if the lump sum were discounted back for more periods. d. The present value of the $1,000 would be larger if interest were compounded monthly rather than semiannually. e. The PV of the $1,000 lump sum has a smaller present value than the PV of a 3-year, $333.33 ordinary annuity. 11. Which of the following investments would have the highest future value at the end of 10 years? Assume that the effective annual rate for all investments is the same and is greater than zero. a. Investment A pays $250 at the beginning of every year for the next 10 years (a total of 10 payments). b. Investment B pays $125 at the end of every 6-month period for the next 10 years (a total of 20 payments). c. Investment C pays $125 at the beginning of every 6-month period for the next 10 years (a total of 20 payments). d. Investment D pays $2,500 at the end of 10 years (just one payment). e. Investment E pays $250 at the end of every year for the next 10 years (a total of 10 payments). 12. You plan to analyze the value of a potential investment by calculating the sum of the present values of its expected cash flows. Which of the following would increase the calculated value of the investment? a. The cash flows are in the form of a deferred annuity, and they total to $100,000. You learn that the annuity lasts for 10 years rather than 5 years, hence that each payment is for $10,000 rather than for $20,000. b. The discount rate decreases. c. The riskiness of the investments cash flows increases. d. The total amount of cash flows remains the same, but more of the cash flows are received in the later years and less are received in the earlier years. e. The discount rate increases. 13. Which of the following statements regarding a 15-year (180-month) $125,000, fixed-rate mortgage is CORRECT? (Ignore taxes and transactions costs.) a. The remaining balance after three years will be $125,000 less one third of the interest paid during the first three years. b. Because it is a fixed-rate mortgage, the monthly loan payments (which include both interest and principal payments) are constant. c. Interest payments on the mortgage will increase steadily over time, but the total amount of each payment will remain constant. d. The proportion of the monthly payment that goes towards repayment of principal will be lower 10 years from now than it will be the first year. e. The outstanding balance declines at a slower rate in the later years of the loans life. 14. Your bank account pays an 8% nominal rate of interest. The interest is compounded quarterly. Which of the following statements is CORRECT? a. The periodic rate of interest is 2% and the effective rate of interest is 4%. b. The periodic rate of interest is 8% and the effective rate of interest is greater than 8%. c. The periodic rate of interest is 4% and the effective rate of interest is less than 8%. d. The periodic rate of interest is 2% and the effective rate of interest is greater than 8%. e. The periodic rate of interest is 8% and the effective rate of interest is also 8%. 15. Which of the following statements is CORRECT? a. The present value of a 3-year, $150 annuity due will exceed the present value of a 3-year, $150 ordinary annuity. b. If a loan has a nominal annual rate of 8%, then the effective rate can never be greater than 8%. c. If a loan or investment has annual payments, then the effective, periodic, and nominal rates of interest will all be different. d. The proportion of the payment that goes toward interest on a fully amortized loan increases over time. e. An investment that has a nominal rate of 6% with semiannual payments will have an effective rate that is smaller than 6%. 16. Your father is about to retire, and he wants to buy an annuity that will provide him with $85,000 of income a year for 25 years, with the first payment coming immediately. The going rate on such annuities is 5.15%. How much would it cost him to buy the annuity today? a. $1,063,968 b. $1,119,966 c. $1,178,912 d. $1,240,960 e. $1,303,008 17. Your aunt is about to retire, and she wants to sell some of her stock and buy an annuity that will provide her with income of $50,000 per year for 30 years, beginning a year from today. The going rate on such annuities is 7.25%. How much would it cost her to buy such an annuity today? a. $574,924 b. $605,183 c. $635,442 d. $667,214 e. $700,575 18. What is the present value of the following cash flow stream at a rate of 8.0%? Years: 0 1 2 3  | | | | CFs: $750 $2,450 $3,175 $4,400 a. $7,917 b. $8,333 c. $8,772 d. $9,233 e. $9,695 19. You want to go to Europe 5 years from now, and you can save $3,100 per year, beginning one year from today. You plan to deposit the funds in a mutual fund that you think will return 8.5% per year. Under these conditions, how much would you have just after you make the 5th deposit, 5 years from now? a. $18,369 b. $19,287 c. $20,251 d. $21,264 e. $22,327 20. You plan to invest some money in a bank account. Which of the following banks provides you with the highest effective rate of interest? a. Bank 1; 6.1% with annual compounding. b. Bank 2; 6.0% with monthly compounding. c. Bank 3; 6.0% with annual compounding. d. Bank 4; 6.0% with quarterly compounding. e. Bank 5; 6.0% with daily (365-day) compounding. 21. Suppose your credit card issuer states that it charges a 15.00% nominal annual rate, but you must make monthly payments, which amounts to monthly compounding. What is the effective annual rate? a. 15.27% b. 16.08% c. 16.88% d. 17.72% e. 18.61% 22. Your uncle will sell you his bicycle shop for $250,000, with "seller financing," at a 6.0% nominal annual rate. The terms of the loan would require you to make 12 equal end-of-month payments per year for 4 years, and then make an additional final (balloon) payment of $50,000 at the end of the last month. What would your equal monthly payments be? a. $4,029.37 b. $4,241.44 c. $4,464.67 d. $4,699.66 e. $4,947.01 23. You plan to borrow $35,000 at a 7.5% annual interest rate. The terms require you to amortize the loan with 7 equal end-of-year payments. How much interest would you be paying in Year 2? a. $1,994.49 b. $2,099.46 c. $2,209.96 d. $2,326.27 e. $2,442.59 24. Assuming the pure expectations theory is correct, which of the following statements is CORRECT? a. If 2-year Treasury bond rates exceed 1-year rates, then the market must expect interest rates to rise. b. If both 2-year and 3-year Treasury rates are 7%, then 5-year rates must also be 7%. c. If 1-year rates are 6% and 2-year rates are 7%, then the market expects 1-year rates to be 6.5% in one year. d. Reinvestment rate risk is higher on long-term bonds, and interest rate price risk is higher on short-term bonds. e. Interest rate price risk and reinvestment rate risk are relevant to investors in corporate bonds, but these concepts do not apply to Treasury bonds. 25. Assume that interest rates on 20-year Treasury and corporate bonds are as follows: T-bond = 7.72% AAA = 8.72% A = 9.64% BBB = 10.18% The differences in these rates were probably caused primarily by: a. Tax effects. b. Default risk differences. c. Maturity risk differences. d. Inflation differences. e. Real risk-free rate differences. 26. Assume that inflation is expected to decline steadily in the future, but that the real risk-free rate, r*, will remain constant. Which of the following statements is CORRECT, other things held constant? a. If the pure expectations theory holds, the Treasury yield curve must be downward sloping. b. If the pure expectations theory holds, the corporate yield curve must be downward sloping. c. If there is a positive maturity risk premium, the Treasury yield curve must be upward sloping. d. If inflation is expected to decline, there can be no maturity risk premium. e. The expectations theory cannot hold if inflation is decreasing. 27. Which of the following statements is CORRECT? a. The yield on a 3-year Treasury bond cannot exceed the yield on a 10-year Treasury bond. b. The yield on a 2-year corporate bond should always exceed the yield on a 2-year Treasury bond. c. The yield on a 3-year corporate bond should always exceed the yield on a 2-year corporate bond. d. The yield on a 10-year AAA-rated corporate bond should always exceed the yield on a 5-year AAA-rated corporate bond. e. The following represents a "possibly reasonable" formula for the maturity risk premium on bonds: MRP = -0.1%(t), where t is the years to maturity. 28. Suppose 1-year Treasury bonds yield 4.00% while 2-year T-bonds yield 5.10%. Assuming the pure expectations theory is correct, and thus the maturity risk premium for T-bonds is zero, what is the yield on a 1-year T-bond expected to be one year from now? a. 5.90% b. 6.21% c. 6.52% d. 6.85% e. 7.19% 29. Suppose 1-year T-bills currently yield 7.00% and the future inflation rate is expected to be constant at 3.20% per year. What is the real risk-free rate of return, r*? Disregard any cross-product terms, i.e., if averaging is required, use the arithmetic average. a. 3.80% b. 3.99% c. 4.19% d. 4.40% e. 4.62% 30. Keys Corporation's 5-year bonds yield 6.20% and 5-year T-bonds yield 4.40%. The real risk-free rate is r* = 2.5%, the inflation premium for 5-year bonds is IP = 1.50%, the liquidity premium for Keys' bonds is LP = 0.5% versus zero for T-bonds, and the maturity risk premium for all bonds is found with the formula MRP = (t 1) 0.1%, where t = number of years to maturity. What is the default risk premium (DRP) on Keys' bonds? a. 1.17% b. 1.30% c. 1.43% d. 1.57% e. 1.73%  EMBED Excel.Sheet.8   EMBED Excel.Sheet.8      V1 -  PAGE 9 - !#$*./78CWh}" A  ( * q s 9:ⷬ}tk`k`k`k`kZ hC^Jh{hC@^Jh{hC^Jh[IhC^J h#^Jhhzh5>*OJQJ^JhXs>*OJQJ^JhXsOJQJ^Jh>*OJQJ^JhOJQJ^J"hXshXs5CJ OJQJ\^JhXs5CJ OJQJ\^Jh5CJ OJQJ\^Jh#5CJ OJQJ\^J"89}~ A B   b B 9:k 0^`0gdFn< 8^8`gdC  | ).$gdC 0^`0gdCgd$a$gd$a$gd:;}:;GPOYafk  ,07<GHIblz{ӿӿ܃xh{h;]M@^Jh{h;]M^JhFn<hFn<>*^JhFn<hFn<@^JhFn<hFn<^JhFn<hb>*^JhFn<hb@^JhFn<hb^Jh{hb@^Jh{hb^J h#^Jhqh{hFn<@^Jh{hFn<^J hFn<^J/kl:wKLGHyz  | ).$gd;]M 0^`0gd;]M 8^8`gdb  | ).$gdb 0^`0gdb 8^8`gdFn< |gdFn<JN{| /013:S\opú歟~ttmih hUX5>*h#R*h5>* h#hh# h#h#hh5OJQJ^Jhl,h5OJQJ^Jh{hS^JhIhJ6hI^J hI^Jhj)hFn<^Jh{hFn<@^Jh{hFn<^J hFn<^Jh{h;]M^Jh{h;]M@^J)z{Gv  | ).$gdFn<gdI 8^8`gdI %#$gdI `080^`0gdIgdFn< 8^8`gdFn< 8^8`gd;]M/0   h^hgd & Fgd# & Fgd# & Fgdgd#gd  ?[  !  "$%&')5oprsǸǸhR3khM+^J hU (^J hM+^Jhnkh0hh#hL@K h5h#R*h5h#R*h5>*hhF !#$ 1op45 ~ o$gdM+ <P"$gdM+ 8^8`gdM+ 0^`0gdM+ & Fgd# & Fgd#h^hgd45V_,5( ) + , !!'"0"?"E""""""##&&&&&&''r'{'''+(4(R(S(U(V(((****o+z+++%,-,/,0,Q-R-------Ƽh%hM+>*^Jh%hM+^J hp^JhHhM+@^J hU (^J hM+^JhR3khM+^JhR3khM+>*^JJ~( ) !!2""""""""""""## $$%% o$gdM+ 0^`0gdM+ 8^8`gdM+%&&&&C'''R(S((((a))N***++ iO$(&+gdM+ o$gdM+ 0^`0gdM+ <P"$gdM+ 8^8`gdM++++ ,,%,&,',(,),*,+,,,-,Q-R-^-j-v--- iO$(&+gdM+ 0^`0gdM+ <P"$gdM+ n"'o+08^8`gdM+------..&.0.:.D.N.O.// <P"$gdM+ n"'o+08^8`gdM+ iO$(&+gdM+ @  !$^gdM+ $gdM+ 0^`0gdM+ $(&+gdM+-------..N.P.Q.R./////////G0H0"1#1$1%1&1'11111222 2!23333333|444444h7i7j78888@;A;B;C;D;==>հհհհհh;ho^Jh;hM+^Jh%hM+>*^JhM+5\^JhR3khM+^J ho^J hp^JjhM+U^JmHnHu hM+^Jh%hM+^JB///////G0H0q0000"1#1$111 iO$(&+gdM+ <P"$gdM+gdM+ 8^8`gdM+ o$gdM+ 0^`0gdM+ n"'o+08^8`gdM+111 2222333333334444444 $(&+gdM+ iO$(&+gdM+ 0^`0gdM+ n"'o+08^8`gdM+4*555[66g7h777775868F8c888 gdM+ ^gdM+ gdM+ x$^gdM+ k K? gdM+ ?o gdM+ 8^8`gdM+ 0^`0gdM+888999L:::@;A;B;t;u;;2<< ===> gdM+ 0^`0gdM+ ?o gdM+ 8^8`gdM+>>>>>>>>>????@ @@@AAAAAA 0^`0gdM+ ?o gdM+ $gdM+ n"'o+08^8`gdM+>>>>>@@AAAABBBBBBBB.B/B0B1B4B5B7B8B:B;B=B>B@BBBEBFBLBMBNBOBSBTBUBûֱҚ֩~v~vmv~hImHnHujh\3Uh\3h Vh,,jh,,UjYh1JmUjdQ h1JmCJUVaJh4hqhOJQJ^Jjh\]UjO h\]CJUVaJhg}jhg}Uhah{hFn<^J ho^Jh;hM+^J hM+^J)AAAAABBBBB2B3B4B6B7B9B:B^@KeeOS$nJT$??\$|\>R }AޏFI?o:qp~בSKb=FGm5׿6hMm|懠Y| ix#/U/o..T;{Scm7!EH'X['얒Ƿyz~,(&U QomS,핊 [,Y >l8ς^ OD @]"IjɌw(Юӽ s*R>O;h(tӮc;ʱ!iIڱEڳyWψzhyN[ װA4\*!uwϗ6Ilhs+D9hI 5KD MR;m`h La buĠl`ژzl`6p"w52m[1$գl`>-:lojHm@_h6 韟P´1;/>чgBBuHk6"Avv~Ōl,5><[ K-EI F92H@=7 |. :#6ڕyb_&ސߠCkrO.`AUYEQ }?iAy]Tg#Y^Ucs7(/ P^uψ3oCW g.8sbXgO?ހ\\_>ʖۄ<80|8y1#?QeP}CjFPV7vvYgaFYGYȊZRvdApby,b`*{)X%C҂7&}3u(8ЄaG6O2vdC?LVƎ_@|7yiiG*C: ڐ'!e8/S-sΨӽNw8iDZat/94s7~ .~1HS!퇴qC*+uU3~P/7'?RO8cCՀ.}cu9@G>qᇛiPij6B:X?b>M,u"Ǝ|ēsqчT9'#UVBzfd<,Vrq|W 8O%,fKwP WZ)6U*L}MDRq'<0|mʗM4dq)/_26M^.c9pW%GVS F^rUK?:y|iigF3F\#jX}I^9;&Z!>A~#.{,npV 1"=~_g/N^qfI.qI|O66Qeajx!6evq.í:WjT[!naٝ!>9^/a,3e,.ٹ0ےgY6~$~|cp?v?>d"+= _I0eAVFzns478u!œ`YZ-m,h :1V[3qcqK$ޜb-7yb۸us-n|oqig׸_Xg6:}D "3mS%-FU?CM^JgHݟq}i o,E/徢Nq%nf &jGKW. :E#KW.KU. 0\kW9%Fx5,|4Ly]]F g̤X68u3rUY'jBWn?ð,lsrbܛ*x!VOq}5i̇O3í&xlp1,,:X~ xmMff|}n&TܬFzs4֔՝*(s4qՔu6'Ya[kVF YW &g| &,4N}@zb.t_5_`/yOT\ S*s].6jn)_ceas&Urǟu&udHG=P&>UYrޙ~j"DTg#Oa|5e|$OaF9MKO<-o#n Yo˱eꍓ=CT^= A|<߁>z?=ssa6)cd ؆ zeæ"l*~lԽOo|T݂MݻmۈmĂMݫ~+g$blf_{/F~EO llńXGmm 6CGmm6GGhH|ؚ ll(uغ,غ[zz m66 mm>> }m  턖yy ېmȂmoXlφ F[ĂxA>Jle2 2V(,[  !"#$%&'()*+,-./0123456789;<=>?@ADwHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvz{|}~Root Entry F=hF Data :&WordDocument4rObjectPoolc=h_1337980551  FccOle EPRINTG$^CompObjm  !#$%&') F!Microsoft Office Excel WorksheetBiff8Excel.Sheet.89q Oh+'0@H\x  markmoorMark Ernst MooreMicrosoft Excel@ũ@@(` l> J8.F EMF$^$J*V"F, EMF+@XXF\PEMF+"@ @ $@ 0@?!@ @     !" !" !  " !  R " !  R Rp Calibri:0:&X0: L0: :0: V0 Calibrit0|% &% !:0dv% % " !%   R y  TH{w/@@*LCantel Medical Corp. (CMN) - Balance Sheet1,0.O.0',11 01O;2,,0'.*0..% " !%   R % " !%   R k  Tqi/@@ LhPERIOD ENDINGee0-2=9-;9;:TLi/@@L L`31-Jul-07ee//0//T i/@@ L`31-Jul-08ee//0//T > i/@@ L`31-Jul-09ee//0//% " !%   R Rp CalibritVm0vVm&X0tVm L0tVm :0tVm V0 Calibrit0| & !tVm0dv% % " !%   sR   Tps/@@rLXAssets8%%. %% " !%   R % % " !%   R ]  T4[/@@LhCurrent Assets10 .05$$.$% " !%   R % " !%   eR   TSe6/@@SdLCash And Cash Equivalents1,$05001,$0-00*,.0$Tpe/@@dLX15,860/////Tp e /@@ dLX18,318/////Tp= e> /@@= dLX23,368/////% " !%   R % " !%   R O  TSM/@@SLxShort Term Investments*01 -. J0*.$J.0$TlM/@@LX1,579////Tl  M/@@ LX2,560////Tll > M/@@l LX3,994////% " !%   R % " !%   WR   TSW/@@SVLAccounts Receivable (net)5''100$2.'.*,0.0.TpW/@@VLX31,972/////Tp W /@@ VLX31,881/////Tp= W> /@@= VLX32,348/////% " !%   R % " !%   R A  TS?/@@S L`Inventory90*.01 *Tp?/@@LX27,320/////Tp  ?/@@ LX31,802/////Tp= > ?/@@= LX29,200/////% " !%   R % % " !%   IR   TI/@@HLtTotal Current Assets.1 -11!!.1 8%%. %TpI/@@HLX76,731/////Tp I /@@ HLX84,561/////Tp< I> /@@< HLX88,910/////% " !%   R % % " !%   R 3  T1/@@LxLong Term Investmentsv'10+-. J0*.$J.0$Tl1/@@LX1,675n////Tl  1/@@ LX1,497 ////T` > 1/@@ LT956n///% " !%   R % " !%   ;R   T;/@@:LProperty Plant and Equipment0 10. *0,0,00-000J.0Tp;/@@:LX38,577/////Tp ; /@@ :LX37,920/////Tp= ;> /@@= :LX35,968/////% " !%   R % " !%   R %  T|`#/@@L\Goodwill:110BTxq#/@@qL\102,073//////Tx  #/@@ L\113,958//////Tx > #/@@ L\114,995//////% " !%   R % " !%   -R   T-/@@,LpIntangible Assets 0,0+0.5$$.$Tp-/@@,LX44,615/////Tp - /@@ ,LX41,254/////Tp= -> /@@= ,LX37,042/////% " !%   R % % " !%   R   TQ/@@L|Total Non-Current Assets.1 -=1111!!.1 8%%. %Txp/@@pL\186,940//////Tx  /@@ L\194,629//////Tx > /@@ L\188,961//////% " !%   R % " !%   R   T/@@ LdTotal Assets.1 -8%%. %Txp/@@pL\263,671//////Tx  /@@ L\279,190//////Tx > /@@ L\277,871//////% " !%   R % " !%   R   T~/@@ LdLiabilities'-1 .%% " !%   R % % " !%   R   T/@@LtCurrent Liabilities10 .0',0.$% " !%   R % " !%    R t   TS r /@@S LlAccounts Payable5''100$0,*,0.Tp r /@@ LX28,168/////Tp  r /@@  LX28,002/////Tp=  > r /@@=  LX26,294/////% " !%   R % " !%   | R   TS| j /@@S{ !LCurrent Portion of Long Term Debt10 .001 101'10+-. J9.0Tl|  /@@{ LX6,000////Tl | /@@ { LX8,000I////Tp= | > /@@= { LX10,000/////% " !%   R % " !%    R f   TS d /@@S L|Notes Payable - Currentt;1.$0,*,0.10 .0Tl d /@@ LX1,803 ////Tl d /@@ LX2,920t////Tll > d /@@l LX2,819 ////% " !%   R % % " !%   n R   Tn  /@@m LTotal Current Liabilitiesp.1 -11!!.1 '-1 .%Tpn  /@@m LX35,971/////Tp n /@@ m LX38,922/////Tp< n > /@@< m LX39,113/////% " !%   R % % " !%    R X   T kV /@@ LhLong Term Debt'10+-. J9.0Tp V /@@ LX51,000/////Tp V /@@ LX50,300/////Tp= > V /@@= LX33,300/////% " !%   R % " !%   ` R   T` J /@@_ LOther Non-Current Liabilities =0. ;1010 .0',0.$Tp`  /@@_ LX21,630/////Tp ` /@@ _ LX21,256/////Tp= ` > /@@= _ LX18,342/////% " !%   R % % " !%    R J   TS H /@@S LTotal Non-Current Liabilities.1 -=1111!!.1 '-1 .%Tp H /@@ LX72,630/////Tp H /@@ LX71,556/////Tp< > H /@@< LX51,642/////% " !%   R % " !%   R R   TR  /@@Q LpTotal Liabilities.1 -'-1 .%TxpR  /@@pQ L\108,601//////Tx R /@@ Q L\110,478//////Tp< R > /@@< Q LX90,755/////% " !%   R % % " !%    R <   T : /@@ LtStockholders' Equity*1'*010. $-00*% " !%   R % " !%   D R   TD J /@@C LdCommon Stock11JJ10*1'*TlD  /@@C LX1,713////Tl D /@@ C LX1,752////Tll D > /@@l C LX1,788////% " !%   R % " !%    R .  T ,/@@ LpRetained Earnings2.,0.0-, 00+$Tp ,/@@ LX77,841/////Tp ,/@@ LX86,534/////Tx > ,/@@ L\102,103//////% " !%   R % " !%   6R   T68/@@5LhTreasury Stock- .,$0 **1'*Tp6/@@5LX-9,821////Tx 6 /@@ 5L\-11,340/////Tx! 6> /@@! 5L\-12,225/////% " !%   R % " !%   R   T=/@@LlCapital Surplus1,0,*0 00$Tp/@@LX76,843/////Tp  /@@ LX81,475/////Tp= > /@@= LX87,169/////% " !%   R % " !%   (R   T(/@@'L|Other Stockholder Equity=0. *1'*010. -00*Tl(/@@'LX8,494////Tp ( /@@ 'LX10,291/////Tll (> /@@l 'LX8,281////% " !%   R % % " !%   R   T8/@@L|Total Stockholder Equity.1 -+ 1',111.!-11 ,Txp/@@pL\155,070//////Tx  /@@ L\168,712//////Tx > /@@ L\187,116//////% " !%   R % " !%   R   T/@@LTotal Liabilities and Equity.1 -'-1 .%-11-11 ,Txp/@@pL\263,671//////Tx  /@@ L\279,190//////Tx > /@@ L\277,871//////% " !%   R % ( ( " F4(EMF+*@$??FEMF+@ ObjInfo WorkbookyQSummaryInformation( DocumentSummaryInformation8@ - \pMark Ernst Moore Ba=#=--`'3<X@"1Calibri1Calibri1Calibri1Calibri1Calibri1h8Cambria1,8Calibri18Calibri18Calibri1Calibri1Calibri1<Calibri1>Calibri1?Calibri14Calibri14Calibri1 Calibri1 Calibri1Calibri1Calibri1 Calibri1Calibri"$"#,##0_);\("$"#,##0\)!"$"#,##0_);[Red]\("$"#,##0\)""$"#,##0.00_);\("$"#,##0.00\)'""$"#,##0.00_);[Red]\("$"#,##0.00\)7*2_("$"* #,##0_);_("$"* \(#,##0\);_("$"* "-"_);_(@_).))_(* #,##0_);_(* \(#,##0\);_(* "-"_);_(@_)?,:_("$"* #,##0.00_);_("$"* \(#,##0.00\);_("$"* "-"??_);_(@_)6+1_(* #,##0.00_);_(* \(#,##0.00\);_(* "-"??_);_(@_)                                                                       ff + ) , *     P  P        `            a>          ! ! !     ! !  20% - Accent1 20% - Accent2 20% - Accent3 20% - Accent4 20% - Accent5 20% - Accent6 40% - Accent1 40% - Accent2 40% - Accent3 40% - Accent4 40% - Accent5 40% - Accent6 60% - Accent1 60% - Accent2 60% - Accent3 60% - Accent4 60% - Accent5! 60% - Accent6 "Accent1 #Accent2 $Accent3 %Accent4 &Accent5 'Accent6(Bad) Calculation* Check Cell+,-./Explanatory Text 0Good1 Heading 12 Heading 23 Heading 34 Heading 4 5Input6 Linked Cell 7Neutral 8Note 9Output: ;Title <Total= Warning Text`Cantel Med Income Stmt# Balance Sheetu7Income and Cash FlowA Cash Flow"O PERIOD ENDING Total RevenueCost of Revenue Gross ProfitOperating ExpensesResearch Development"Selling General and Administrative Non Recurring- OthersTotal Operating ExpensesOperating Income or Loss!Income from Continuing OperationsTotal Other Income/Expenses Net"Earnings Before Interest And TaxesInterest ExpenseIncome Before TaxIncome Tax ExpenseMinority InterestNet Income From Continuing OpsNon-recurring EventsDiscontinued OperationsExtraordinary ItemsEffect Of Accounting Changes Other Items Net Income%Preferred Stock And Other Adjustments&Net Income Applicable To Common SharesCantel Medical Corp. (CMN)AssetsCurrent AssetsCash And Cash EquivalentsShort Term Investments InventoryTotal Current AssetsLong Term InvestmentsProperty Plant and EquipmentGoodwillIntangible Assets Total Assets LiabilitiesCurrent LiabilitiesAccounts PayableTotal Current LiabilitiesLong Term DebtTotal LiabilitiesStockholders' Equity Common StockRetained EarningsTreasury StockCapital SurplusOther Stockholder EquityTotal Stockholder Equity)Total Cash Flow From Operating ActivitiesCapital Expenditures Investments)Other Cashflows from Investing Activities*Total Cash Flows From Investing ActivitiesDividends PaidSale Purchase of StockNet Borrowings*Other Cash Flows from Financing Activities*Total Cash Flows From Financing Activities!Current Portion of Long Term DebtNotes Payable - CurrentOther Non-Current LiabilitiesTotal Non-Current AssetsTotal Non-Current LiabilitiesTotal Liabilities and Equity2Accrual Adjustments to compute Operating Cash FlowInvesting Activities Cash FlowsFinancing Activities Cash Flows#Accrual Adjustments to compute CFFOCommon Shares Outstanding-Cantel Medical Corp. (CMN) - Income Statement0Cantel Medical Corp. (CMN) - Cash Flow Statement*Cantel Medical Corp. (CMN) - Balance SheetCantel Medical Corp. provides infection prevention and control products in the healthcare market. It operates in six segments: Water Purification and Filtration, Healthcare Disposables, Dialysis, Endoscope Reprocessing, Therapeutic Filtration, and SpecialAccounts Receivable (net)R4 q]5[3+8 -   dMbP?_*+%,&ffffff?'ffffff?(?)?",ERIO333333?333333? RU} m'} m!} } ,,,,,,,, , , , ,,,,,,,,,,,,,,,,,  AM > @>]@>/@  ?A?pA? A  ?ؙA?A?A  ?pI@?d@?@J@   ?@?T@?@  ?@t@?@?@                      ?@?@?q@     b@@@  ?@? @?2@ ?@?@?h@ ?_@? @?@ ?U@?&@?n@     ?h@?@?@     ~ `u@             ?h@?@?@     @h@@@@@<0::::,BBPPP:,B4444B4(BBBB4B>@?7ggD -   dMbP?_*+%,&ffffff?'ffffff?(?)?MSamsung ML-1740 Series odXXLetterPRIVp dCourier NewH"dX333333?333333?U} I"}  } I }  $,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, , L  >/@>]@> @ F    B?@?@?@ B ?@?@?4@ BN?9@?@"@?@ B! ?@?@?@ D" E@E@E@ # ?,@?d@@ $ ? @?@?@ % ?@?`@?0@ &?@?$@?@@ DB!EA DD !E(A DD !EA DD  F'EAEX AEA??? F(  )  B*?@?X@?@ B??p@?@@?@ B@?,@?Ц@?@ D+E`@E@@E @ ,?@?@?B@ A?@?@?@ GC!E`@ DD!E@x@ DD!E@7@ DD D-E@E@E0(@ .  /?Ě@?`@?@ 0?@?` @?p@ 1?.?&? 2 ?@?0@?H@BX**********}*******}****!,",#, !3!?@?@?,@ "D4"EAE@AE`A #FD!#EA D"D!#EX A D"D!#EA D"D (**>@=2  7ggD -   dMbP?_*+%,",??U} $+} } $} $ $,,,,,,, , , , , ,,,,,,,,,,,,,,,,, , J >/@>]@> @  ? A?pA?A  ?A?A?ؙA  GE@J@Ed@EpI@   B?@?T@?@  B ?r@?@?@k@ ? C ! ?@ DD ! ?@ DD ! ?@ DD   H ! E@ DD  E @E@ ?@ B ?h@?@?@  B ?n@?&@?U@  D)E@ D % E@Eh@  IE@Eo@Eo@ FK  >/@>]@> @ ?@?@?h@ H!?^ DD!?D@ DD!?@ DD D5EO@E@@ED@??? FF  B6??w?w B7i B8??U?{ D9EGEE]??? FG  B: B; ?@b@@>B0$::::$::Y::a***}******!,",#, !B<!?@?P@?L "B="@ {@p@ #D>#E@Eh@E (**>@7 -   dMbP?_*+%,&ffffff?'ffffff?(?)?",333333?333333?U} 3} ,,,,,,, , , , , ,,,,,,,,, >/@>]@> @ ?@?@?h@ E!?^ DD!?D@ DD!?@ DD D5EO@E@@ED@??? FF  B6??w?w B7 i B8 ??U?{ D9 EGEE] ??? FG  B: B;?@b@@ B<?@?P@?L B=@ {@p@ D>E@Eh@E~ ?8 ~ @ !?8)A DD ,|**}**********>@7ggD RS<7!,",#,!BNet Borrowings!?@?P@?L3"B*Other Cash Flows from Financing Activities"@ {@p@3#D*Total Cash Flows From Financing Activities#E@Eh@E (7S>@7 -   dMbP?_*+%,&ffffff?'ffffff?(?)?",333333?333333?omU} 3} ,,,,,,, , , , , ,,,,,,,,, PERIOD ENDING>/@>]@> @ Net Income?@?@?h@;2Accrual Adjustments to compute Operating Cash Flow!?^ DD!?D@ DD!?@ DD2D)Total Cash Flow From Operating ActivitiesEO@E@@ED@???(FInvesting Activities Cash Flows BCapital Expenditures??w?w B Investments i2 B)Other Cashflows from Investing Activities ??U?{3 D*Total Cash Flows From Investing Activities EGEE] ???( FFinancing Activities Cash Flows BDividends PaidBSale Purchase of Stock?@b@@BNet Borrowings?@?P@?L3B*Other Cash Flows from Financing Activities@ {@p@3D*Total Cash Flows From Financing ActivitiesE@Eh@E~ ?8 ~ @ !?8)A DD ,o|63R<=4RS<7?7SS>@7ggD ՜.+,0 PXh px BACS' Cantel Med Income StmtBalance SheetIncome and Cash Flow Cash Flow  Worksheets F&Microsoft Office Excel 2003 WorksheetBiff8Excel.Sheet.89q_1361011733 FccOle  EPRINT ZCompObjrl^B.F EMFZeU"F, EMF+@XXF\PEMF+"@ @ $@ 0@?!@ @     !" !" !  " !  " !  " !  " !  Rp Calibri)[`2p[w~`Y`2x'0~~0~P0p[w P01I00I0(!H &XH 08wP`w(!09pHk2(!09dv% % " !%   y  T\"wU@@-LCantel Medical Corp. (CMN) - Income StatementR1,0.O.0',11 01O;0'1J.*,.J.0% " !%   % " !%   k  TqiU@@ LhPERIOD ENDING.0-2=9-;9;:T> iU@@> L`31-Jul-07s//0//T , iU@@ L`31-Jul-08o//0//TAiU@@A L`31-Jul-09\//0//% " !%   % " !%   s  Ts,U@@r LhTotal Revenue6-1,2.*.00.Txc s U@@c rL\219,044//////Tx s, U@@ rL\249,374W//////TxfsU@@frL\260,050O//////% " !%   % " !%   ]  T[U@@LpCost of Goods Sold11$1:110$*10Txc  [U@@c L\140,0326//////Tx , [U@@ L\161,748h//////Txf[U@@fL\160,571l//////% " !%   Rp Calibri)[`2p[w~`Y`2x'0~~0~P0p[w P01I01I0(! $&X $ 08wP`w(!09pHk2(!09dv% % " !%   e  TSeU@@Sd LdGross Profit;!1%%1!1 Tp e U@@ dLX79,012/////Tp* e, U@@* dLX87,626/////TpeU@@dLX99,479/////% " !%   % % " !%   O  TMU@@LpOperating Expenses=0. ,0+-(0.0$.$% " !%   % " !%   W  TSWU@@SVLtResearch Development2.$., '09.*.10J.0Tl W U@@ VLX4,848////TlZ W, U@@Z VLX4,010////TlWU@@VLX4,632////% " !%   % " !%   A  TSZ?U@@S"LSelling General and Administrative*.0+:.0. ,,0050J0$ ,*.Tp  ?U@@ LX56,212/////Tp+ , ?U@@+ LX65,134/////Tp?U@@LX67,252/////% " !%   % " !%   I  TIHU@@HL|Total Operating Expenses-1,=0. ,0+-(0.0$.$Tp I U@@ HLX61,060/////Tp+ I, U@@+ HLX69,144/////TpIU@@HLX71,884/////% " !%   % % " !%   3  T1U@@L|Operating Income or Loss>1.!- 1,1'1K.1!'1%%Tp  1U@@ LX17,952/////Tp* , 1U@@* LX18,482/////Tp1U@@LX27,595/////% " !%   % % " !%   ;  TS;U@@S:LlInterest Expense0. .$-(0.0$.Tl ; U@@ :LX3,508////TlZ ;, U@@Z :LX4,631////Tl;U@@:LX2,639////% " !%   % " !%   %  TSI#U@@SLpIncome Tax Expense0'1J.-,(-(0.0$.Tl  #U@@ LX5,998////TlZ , #U@@Z LX5,158(p////Tl#U@@LX9,387////% " !%   % % " !%   -  T-LU@@, L`Net Income=. 1'1K.Tl - U@@ ,LX8,446////TlY -, U@@Y ,LX8,693////Tp-U@@,LX15,569/////% " !%   % % " !%     TWU@@LCommon Shares Outstanding11JJ10*0, .$=0$,000+% Tp  U@@ LX15,420/////Tp* , U@@* LX16,840/////TpU@@LX16,840/////% " !%   % " !%     TlU@@0LCantel Medical Corp. (CMN) - Cash Flow Statement1-1 .P.1'-11!11P=1-%1*1E+ - .K.1 % " !%   % % " !%     TqU@@ LhPERIOD ENDING0-2=9-;9;:T>  U@@>  L`31-Jul-07//0//T , U@@  L`31-Jul-08//0//TAU@@A L`31-Jul-09//0//% " !%   % " !%    t   T r U@@ L`Net Income;.0'1J.Tl  r U@@  LX8,446////TlZ  , r U@@Z  LX8,693////Tp r U@@ LX15,569/////% " !%   % " !%   |    T |  U@@{ #LAccrual Adjustments to compute CFFO5'' 0,500$J.0$1'1J00.1**=Tp | U@@ { LX-2,479////TlZ | , U@@Z { LX9,864////Tp|  U@@{ LX15,423/////% " !%   % % " !%    f   TD d U@@ )LTotal Cash Flow From Operating Activities.1 -1-%1*1E*!1K>1.!- 1,8' , .%Tl d U@@ LX5,967////Tp* , d U@@* LX18,557/////Tp d U@@ LX30,992/////% " !%   % " !%    X   T V U@@ LInvesting Activities Cash Flows1,.% 1,8' , .%1-%1*1E%% " !%   % % " !%   `    TS` R U@@S_ LtCapital Expenditures1,0,-(0.000 .$Tp ` U@@ _ LX-5,529////Tp> ` , U@@> _ LX-4,983////Tp`  U@@_ LX-4,215////% " !%   % " !%    J   TS H U@@S LdInvestments0*.$J.0$TTe H U@@e LP0/TT , H U@@ LP0/Td H U@@ LT-200///% " !%   % " !%   R    TDSR W U@@SQ )LOther Cashflows from Investing Activities=0. 1,$01B$ 1J0*.$0+5'*.$Txv R U@@v Q L\-36,006/////Tx R , U@@ Q L\-13,483/////TpR  U@@Q LX-7,035////% " !%   % % " !%    <   TH : U@@ *LTotal Cash Flows From Investing Activities.1 -1-%1*1E%*!1K1,.% 1,8' , .%Txu : U@@u L\-41,535/////Tx , : U@@ L\-18,466/////Txx : U@@x L\-11,450/////% " !%   % " !%    .  T ,U@@ LFinancing Activities Cash Flows*1-1'1,8' , .%1-%1*1E%% " !%   % % " !%   6  TS6wU@@S5LhDividends Paid9*0.00$0,0TTe 6 U@@e 5LP0/TT 6, U@@ 5LP0/Td6U@@5LT-842///% " !%   % " !%      TSU@@SLxSale Purchase of Stock*,.00 '0,$.1*1'*Tl  U@@ LX1,376////T` , U@@ LT148///TThU@@hLP0/% " !%   % " !%   (  TS(U@@S'LhNet Borrowings;.21 1B0+$Tp ( U@@ 'LX19,000/////TlZ (, U@@Z 'LX1,300////Txy(U@@y'L\-15,000/////% " !%   % " !%     THSU@@S*LOther Cash Flows from Financing Activities=0. 1,$0*1B$ 1J*0,0'0+5'*.$T`  U@@ LT706///T` , U@@ LT434///TdU@@LT2022////% " !%   % % " !%     THU@@*LTotal Cash Flows From Financing Activities.1 -1-%1*1E%*!1K*1-1'1,8' , .%Tp  U@@ LX21,082/////TlY , U@@Y LX1,882////TxxU@@xL\-13,820/////% " !%   % ( ( " F4(EMF+*@$??FEMF+@ ObjInfoWorkbookdsSummaryInformation(DocumentSummaryInformation8@ Oh+'0@H\p  markmoor markmoorMicrosoft Excel@ũ@@՜.+,0 PXh px BACS      6 !"#$%&'()*+,-./012345 \pmarkmoor Ba=#=--,3<X@"1UCalibri1UCalibri1UCalibri1UCalibri1UCalibri1h8UCambria1,8UCalibri18UCalibri18UCalibri1UCalibri1UCalibri1<UCalibri1>UCalibri1?UCalibri14UCalibri14UCalibri1 UCalibri1 UCalibri1UCalibri1UCalibri1 UCalibri1UCalibri"$"#,##0_);\("$"#,##0\)!"$"#,##0_);[Red]\("$"#,##0\)""$"#,##0.00_);\("$"#,##0.00\)'""$"#,##0.00_);[Red]\("$"#,##0.00\)7*2_("$"* #,##0_);_("$"* \(#,##0\);_("$"* "-"_);_(@_).))_(* #,##0_);_(* \(#,##0\);_(* "-"_);_(@_)?,:_("$"* #,##0.00_);_("$"* \(#,##0.00\);_("$"* "-"??_);_(@_)6+1_(* #,##0.00_);_(* \(#,##0.00\);_(* "-"??_);_(@_)                                                                      ff + ) , *     P  P        `            a>          ! ! !    ! !  20% - Accent10 20% - Accent1 20% - Accent20" 20% - Accent2 20% - Accent30& 20% - Accent3 20% - Accent40* 20% - Accent4 20% - Accent50. 20% - Accent5 20% - Accent602 20% - Accent6 40% - Accent10 40% - Accent1 40% - Accent20# 40% - Accent2 40% - Accent30' 40% - Accent3 40% - Accent40+ 40% - Accent4 40% - Accent50/ 40% - Accent5 40% - Accent603 40% - Accent6 60% - Accent10 60% - Accent1 60% - Accent20$ 60% - Accent2 60% - Accent30( 60% - Accent3 60% - Accent40, 60% - Accent4 60% - Accent500 60% - Accent5! 60% - Accent604 60% - Accent6 "Accent1$Accent1 #Accent2$!Accent2 $Accent3$%Accent3 %Accent4$)Accent4 &Accent5$-Accent5 'Accent6$1Accent6(BadBad) Calculation, Calculation* Check Cell* Check Cell+ Comma,( Comma [0]-&Currency.. Currency [0]/Explanatory Text65Explanatory Text 0GoodGood1 Heading 1( Heading 12 Heading 2( Heading 23 Heading 3( Heading 34 Heading 4( Heading 4 5Input Input6 Linked Cell, Linked Cell 7Neutral$Neutral"Normal 8Note Note 9Output"Output:$Percent ;Title Title <Total Total= Warning Text. Warning TextXTableStyleMedium9PivotStyleLight16`"Cantel Med Income StmtM- Balance SheetAIncome and Cash Flowl Cash Flow P PERIOD ENDING Total RevenueCost of Revenue Gross ProfitOperating ExpensesResearch Development"Selling General and Administrative Non Recurring- OthersTotal Operating ExpensesOperating Income or Loss!Income from Continuing OperationsTotal Other Income/Expenses Net"Earnings Before Interest And TaxesInterest ExpenseIncome Before TaxIncome Tax ExpenseMinority InterestNet Income From Continuing OpsNon-recurring EventsDiscontinued OperationsExtraordinary ItemsEffect Of Accounting Changes Other Items Net Income%Preferred Stock And Other Adjustments&Net Income Applicable To Common SharesCantel Medical Corp. (CMN)AssetsCurrent AssetsCash And Cash EquivalentsShort Term InvestmentsNet Receivables InventoryTotal Current AssetsLong Term InvestmentsProperty Plant and EquipmentGoodwillIntangible Assets Total Assets LiabilitiesCurrent LiabilitiesAccounts PayableTotal Current LiabilitiesLong Term DebtTotal LiabilitiesStockholders' Equity Common StockRetained EarningsTreasury StockCapital SurplusOther Stockholder EquityTotal Stockholder Equity)Total Cash Flow From Operating ActivitiesCapital Expenditures Investments)Other Cashflows from Investing Activities*Total Cash Flows From Investing ActivitiesDividends PaidSale Purchase of StockNet Borrowings*Other Cash Flows from Financing Activities*Total Cash Flows From Financing Activities!Current Portion of Long Term DebtNotes Payable - CurrentOther Non-Current LiabilitiesTotal Non-Current AssetsTotal Non-Current LiabilitiesTotal Liabilities and Equity2Accrual Adjustments to compute Operating Cash FlowInvesting Activities Cash FlowsFinancing Activities Cash Flows#Accrual Adjustments to compute CFFOCommon Shares Outstanding-Cantel Medical Corp. (CMN) - Income Statement0Cantel Medical Corp. (CMN) - Cash Flow Statement*Cantel Medical Corp. (CMN) - Balance SheetCantel Medical Corp. provides infection prevention and control products in the healthcare market. It operates in six segments: Water Purification and Filtration, Healthcare Disposables, Dialysis, Endoscope Reprocessing, Therapeutic Filtration, and SpecialCost of Goods SoldR qC5D6 cc   dMbP?_*+%,&ffffff?'ffffff?(?)?",333333?333333? R&43U} m'} m!} } ,,,,,,,, , , , ,,,,,,,,,,,,,,,,,  AN > @>]@>/@  ?A?pA? A  ?ؙA?A?A  ?pI@?d@?@J@   ?@?T@?@  ?@t@?@?@                      ?@?@?q@     b@@@  ?@? @?2@ ?@?@?h@ ?_@? @?@ ?U@?&@?n@     ?h@?@?@     ~ `u@             ?h@?@?@     @h@@@@@<0::::,BBPPP:,B4444B4(BBBB4B>@@B?7ggD   dMbP?_*+%,&ffffff?'ffffff?(?)?MSamsung ML-1740 Series odXXLetterPRIVp dCourier NewH"dX333333?333333?&43U} I"}  } I }  $,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, , M  >/@>]@> @ F    B?@?@?@ B ?@?@?4@ B!?9@?@"@?@ B" ?@?@?@ D# E@E@E@ $ ?,@?d@@ % ? @?@?@ & ?@?`@?0@ '?@?$@?@@ DC!EA DD !E(A DD !EA DD  F(EAEX AEA??? F)  *  B+?@?X@?@ B@?p@?@@?@ BA?,@?Ц@?@ D,E`@E@@E @ -?@?@?B@ B?@?@?@ GD!E`@ DD!E@x@ DD!E@7@ DD D.E@E@E0(@ /  0?Ě@?`@?@ 1?@?` @?p@ 2?.?&? 3 ?@?0@?H@BX**********}*******}****!,",#, !4!?@?@?,@ "D5"EAE@AE`A #FE!#EA D"D!#EX A D"D!#EA D"D (**>@  7ggD   dMbP?_*+%,&?'?(?)?M \\http://goprint.ba.ttu.edu\FNC odXXLetterDINU"8tPT١58SMTJ(HP LaserJet 4240 PCL 6InputBinFORMSOURCERESDLLUniresDLLResolution600dpiFastResTrueOrientationPORTRAITHPOrientRotate180FalseDuplexNONEHPDuplicateJobNameOverrideSWFWPaperSizeLETTERMediaTypeAUTOCollateOFFOutputBinAutoStaplingNoneHPPaperSizeALMConstraintsENV_10EconomodeFalseTextAsBlackFalseHPEnableRAWSpoolingTrueTTAsBitmapsSettingTTModeOutlineJPEGEnableAutoRETChoiceTrueAlternateLetterHeadFalsePrintQualityGroupPQGroup_1HPDocPropResourceDatahpzhl3zw.cabHPColorModeMONOCHROME_MODEHPContentOrientationHPContentOrientation_OptionHPPDLTypePDL_PCL6HPPJLEncodingUTF8HPJobAccountingHPJOBACCT_JOBACNTHPJobByJobOverrideJBJOHPPCL6PassThroughTrueHPXMLFileUsedhpc42406.xmlHPManualDuplexDialogItemsInstructionID_01_FACEDOWN-NOROTATEHPPaperSizeDuplexConstraintsA5HPMediaTypeDuplexConstraintsEXTRA_HEAVYHPManualFeedOrientationFACEDOWNHPOutputBinOrientationFACEDOWNHPManualDuplexDialogModelModelessHPManualDuplexPageOrderEvenPagesFirstHPMapManualFeedToTray1FalseHPManualDuplexPageRotateDriverRotateHPCustomDUplexableRange5.83x8.27_8.5x14HPPrintOnBothSidesManuallyFalseHPPrintInGrayScaleFalseHPStraightPaperPathFalseHPCoversFront_CoverJRConstraintsJRCHDPartialJRHDInstalledJRHDOffJRHDNotInstalledJRHDOffPSAlignmentFileHPZLS3zwPSServicesOptionPrnStat_SID_242_BID_497_HID_15521HPConsumerCustomPaperHPCustomHPPreAnalysisTrueHPLpiSelectionNonePIUPH dLetter [none] [none]Arial4Pd?MARKMOOR<Automatic>0d j.k k m m EXCEL.EXEC:\Program Files\Microsoft Office\Office12\EXCEL.EXE<"dXX??&U} $+} } $} $ $,,,,,,, , , , , ,,,,,,,,,,,,,,,,, , K >/@>]@> @  ? A?pA?A  O?A?A?ؙA  GE@J@Ed@EpI@   B?@?T@?@  B ?r@?@?@k@ ? C ! ?@ DD ! ?@ DD ! ?@ DD   H ! E@ DD  E @E@ ?@ B ?h@?@?@  B ?n@?&@?U@  D)E@ D % E@Eh@  JE@Er@Er@ FL  >/@>]@> @ ?@?@?h@ I!?^ DD!?D@ DD!?@ DD D6EO@E@@ED@??? FG  B7??w?w B8i B9??U?{ D:EGEE]??? FH  B;P B< ?@b@>B0$::::$::Y::a***}******!,",#, !B=!?@?P@?L "B>"@ {@@ #D?#E@Eh@E (**>@EBwd7ggD   dMbP?_*+%,&ffffff?'ffffff?(?)?",333333?333333?&43U} 3} ,,,,,,, , , , , ,,,,,,,,, >/@>]@> @ ?@?@?h@ F!?^ DD!?D@ DD!?@ DD D6EO@E@@ED@??? FG  B7??w?w B8 i B9 ??U?{ D: EGEE] ??? FH  B; B<?@b@@ B=?@?P@?L B>@ {@p@ D?E@Eh@E~ ?8 ~ @ !?8)A DD ,|**}**********>@7ggD Cantel Med Income StmtBalance SheetIncome and Cash Flow Cash Flow  WorksheetsOh+'0 , @L l x  0Exam 1 Version 2 Finance 3320 Summer 2010Mark Ernst Moore Normal.dotm markmoor3d`k`k"lM^[łxA>Jl l-V^[ׂi[߂{A>Jl l,^ii ӄvvɂa(]5]`JخzA>Jl ,15Ă|ئئYM#lbA>Jl)[ʂ-ER %z[[=a(-4-`[HƂ|Z ll5c``!l= %l Xnn ݄mw,G7[D֛pmG_'z}VN{Gש$? 4k\ ; uQurDd %'Xb  c $A? ?3"`?"xc+/YZx,Y@=xc+/YZx,Y\UMVe^xŜmlYǏw2Xy))27}[\qDz]^^C%&uXPUM"R5XEBEb":ڢILDǗa 7C|ǧ>p9s]5v+lU0vxwQkTBXXxhw57k׮me[:Kqddw٧V,W1Jrcw(׺<*bߔ VG6 c}Kt庾τǕ/b;b/_z`k_Dizan_U+G}]a?>U^jfq}>8]n~_n#S omh\ʖV׶gBxY{ \P~^:5X_yb(}%Br/+?OJU( T/fzsbl@]G e3\8gcE4Uas󚁙%Z9Z8ܬg>'rؿΓO$K*O&uqp>:K9AX/׭т\ m._c~G Nު<`CXQ͕,J}Mc#cM{Ymֹ)v^Y'}BK3QTw|ǠLhlj6V^Nk+뵠1~ɏԯj=Evu/5։_W+⫩9NKsv)fzvZM9Eoy9a q/U6}8;u9;f.I+}}lNoEg48;}t*AރfBCgN;eaىz%=e G4>BTUa;' εSkhsOZwm85%s"'1l8M Wʃvk`ߘ< 6IqU_ob|k_yI|JzW^~*sfNs~ 8u?UJ\a/uJذ'ctog|/cU83qY_?eP˟^S4zM#7EFM? E[æ{¤- !=1/mW:ǃاUO}_J+ќ0/b2։AeZ//b2V'԰<̫_\ypQz#ߴOJ망ߏ3{H;56q\A\S [9SZ;{{5|*Wƾ/2F6/ gҜ헍\'inu`ӍݤEa|'o}z?ӷXNkI]C nē:s>pgs>׹TgK5ZiȮ59?#Rƪ)?r)gl^HNJ,+>\9_|Jr|BX[LDuw6qcuns=9I{\Q]6~ }-y{_PǬJ-XwVu~۴l?/Mpߥĕ89VB1f݃p^L9[: @<+H(eyFzv㋜Hy̫5g7}gw:}vcog79'[ē5WߕϲxrxYا1=k OiǼާ<ݛsڟ߬*%w{6z6}\G?m:}XѾ_֧)9Z!]cέϔ=y8yNߜ|3q&mDr'|k/cUsk9 ׏sWubs꿏*O؝ƕ܇~{C]4or5<8/}̙q.Y'81wwkXCb1ͭᔰ{h _Mۥ/2e:Wq߾v~bs#7Sƪ z^sM v>rk0E}^^,cKϙ󺞵p>8qך'_B2ob:Wߓ5a,6ܚLz6,}:7[/-aAc44%$<(AY}ߖORƪ /[OR:w`{WwI~ߔjm0d|:e ^ߔ18LkHai6&sZ86uk\'8G4g*Y?+SÞ Kԉ]x^}'8vKq Wڛk8r83~~HDZ36~ƭ噺'v1l4-l@-QXu4wJ\X_Wn}3,U~|ԯ167)lylW?5M15RǍT^b.u|_]:v39#f}`uh;㜥Ǽq9::`̭㴰-"KsЖ8gMΦ~+'ԯьcψ-yiMx8uF4?")D&nvD6wJ_!qNNjyx^!ǽ3|r&5$M$SbsV9`NmָO NMsk̇ئ1ƵL c'-muF/b2ߜ/U.߻:VLdM1dMɜ1>S_puǜ)ԟo-+Zsԗ16-l@5Ԇ絒_T=[E?Zs3J ̉8{юT\o3q>'5vF"7u4\OQvжϞ}r1ovϪoTOukjyҿ?~ /||Cu|BZwUʻ;;:ߨ3g֕>ڝ/)?{y186%Or5oNcG1F4kL M~ENqM״0Dq[Cmu/{es-nZ‹QvIv֯G5~rB&\0ۧ-eIvJG\vnJV(1ڏJ 1՜.+,0, hp  Texas Tech Universityi: 0Exam 1 Version 2 Finance 3320 Summer 2010 Title^ 2 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH @`@ NormalCJ_HaJmH sH tH DA D Default Paragraph FontRiR  Table Normal4 l4a (k (No List N*N $oEndnote ReferenceCJH*OJQJkH<+< $o Endnote TextCJaJ44  Header  !4 @"4  Footer  !PK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] U:r ":->UB"$&)+06kz ~%+-/148>ASBUB#%'(*,-./12345789:::.:0:U:::"!8@ (  J  # "?B S  ? %U:@ e et OLE_LINK1 _1337980445 _1331428553 _1331428793 _13610117339:.:.:.:V:@@@@::.:.:.:V:} e&V:k&V:9*urn:schemas-microsoft-com:office:smarttagsplace !px$*4:6:7:9:::<:=:?:@:S:V:$*JN U X g .###### $ $$$R%S%^%_%j%k%v%w%%%&&&&'&0&1&:&;&D&E&''''''''''H(O(q(x((((((()))))* ****++++++++++,,,,,,,,,,h11y5}5666666666677777788 8899999999994:6:7:9:::<:=:?:@:S:V:33333333333333333333333333333333333333333333333333333333333333333$*./9|~ B;; H I 03?[ !$99:1:3:4:4:6:7:7:9:::<:=:?:@:E:O:Q:S:V:$*./;; H I 03?[ $9:1:3:4:4:6:7:7:9:::<:=:?:@:S:V:aG9?B@dhl]cPX\!n"d0^`0o(. ^`hH.  L ^ `LhH.   ^ `hH. xx^x`hH. HLH^H`LhH. ^`hH. ^`hH. L^`LhH.^`o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.Q808^8`0o(. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.hh^h`o(.0^`0o(. L^`LhH.   ^ `hH.   ^ `hH. xLx^x`LhH. HH^H`hH. ^`hH. L^`LhH.al]c!n?B@dH9                 #Ra         ޹       _^I\]D  4 iM+4InkQ ##U (2),, 0x0-1\344S7/%:Fn<hEi~EL@K;]M<O;T VUX)ZoZ.\#^b0c4dCecfifh1Jm$oqutJwUq}E>SMXsimHg}^d0Z%7 pDO;soC`s.a`WU5`71 ZE"R54:6:@U:p@UnknownG* Times New Roman5Symbol3. * Arial5. *aTahoma?= * Courier NewA BCambria Math"qhT&[&m1 i1 ix24::3qHX ?/%:2!xx/Exam 1  Version 2  Finance 3320  Summer 2010Mark Ernst Mooremarkmoor      F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q